Early stage IT and Healthcare Investing

Cubist Pharmaceuticals


company snapshot

Cubist Pharmaceuticals

Cubist Pharmaceuticals is focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIND (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. The Cubist product pipeline includes its lipopeptide program and its natural products screening program.

Follow The Company
Investment Team
Facebook Google+ Twitter Email LinkedIn Share